Antimicrobial susceptibility of relatively infrequent isolates of the Bacteroides fragilis group : Bacteroides uniformis, Bacteroides caccae, and Bacteroides eggerthiiALDRIDGE, K. E.Current therapeutic research. 1993, Vol 54, Num 2, pp 208-213, issn 0011-393XArticle

Cross-resistance to β-lactam-β-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis groupALDRIDGE, K. E.Diagnostic microbiology and infectious disease. 1993, Vol 17, Num 3, pp 251-256, issn 0732-8893Article

In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agentsALDRIDGE, K. E.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 4, pp 851-853, issn 0066-4804Article

Cefotaxime in the treatment of staphylococcal infections : comparison of in vitro and in vivo studiesALDRIDGE, K. E.Diagnostic microbiology and infectious disease. 1995, Vol 22, Num 1-2, pp 195-201, issn 0732-8893Conference Paper

Increased activity of new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteriaALDRIDGE, K. E.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 7, pp 1671-1674, issn 0066-4804Article

Antianaerobic activity of various antimicrobial agents against beta-lactamase-positive and -negative strains of the Bacteroides fracilis groupALDRIDGE, K. E.Current therapeutic research. 1992, Vol 52, Num 4, pp 593-599, issn 0011-393XArticle

Major methodology-dependent discordant susceptibility results for Bacteroides fragilis group isolates but not other anaerobesALDRIDGE, K. E; SCHIRO, D. D.Diagnostic microbiology and infectious disease. 1994, Vol 20, Num 3, pp 135-142, issn 0732-8893Article

Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobesALDRIDGE, K. E; ASHCRAFT, D; BOWMAN, K. A et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 2, pp 484-487, issn 0066-4804Article

Increased in vitro activity of ceftriaxone by addition of tazobactam against clinical isolates of anaerobesALDRIDGE, K. E; MORICE, N; SCHIRO, D. D et al.Diagnostic microbiology and infectious disease. 1994, Vol 19, Num 4, pp 227-234, issn 0732-8893Article

Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistanceALDRIDGE, K. E.Acta chirurgica. Supplement. 1994, Num 573, pp 31-37, issn 1102-3309Article

The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infectionsALDRIDGE, K. E.The American journal of surgery. 1995, Vol 169, Num 5A, pp 2S-7S, issn 0002-9610Article

Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyiALDRIDGE, K. E; CAMMARATA, C; MARTIN, D. H et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 9, pp 1986-1988, issn 0066-4804Article

Current antimicrobial therapy of anaerobic infections : Anaerobic bacteria and infectionsSANDERS, C. V; ALDRIDGE, K. E.European journal of clinical microbiology & infectious diseases (Print). 1992, Vol 11, Num 11, pp 999-1011, issn 0934-9723Article

In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agentsALDRIDGE, K. E; HENDERBERG, A; SANDERS, C. V et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 26, Num 3, pp 353-359, issn 0305-7453, 7 p.Article

Comparison of the activity of carumonam (RO 17-2301) with other broad-spectrum antibiotics: in vitro antibacterial spectrum, inoculum effect, and synergy studiesALDRIDGE, K. E; SANDERS, C. V.Current therapeutic research. 1986, Vol 40, Num 3, pp 515-527, issn 0011-393XArticle

Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobesALDRIDGE, K. E; ASHCRAFT, D. S.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 3, pp 709-711, issn 0066-4804Article

Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis groupALDRIDGE, K. E; STRATTON, C. W.Journal of antimicrobial chemotherapy (Print). 1991, Vol 28, Num 5, pp 701-705, issn 0305-7453Article

In vitro Anaerobic data on Ticarcillin/Clavulanate : a review of an ongoing surveySANDERS, C. V; ALDRIDGE, K. E.Journal of reproductive medicine. 1990, Vol 35, Num 3, pp 313-316, issn 0024-7758, 4 p., supplArticle

Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolatesALDRIDGE, K. E; SANDERS, C. V.Journal of clinical microbiology (Print). 1987, Vol 25, Num 12, pp 2317-2321, issn 0095-1137Article

A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methodsALDRIDGE, K. E; JOHNSON, W. D.Journal of antimicrobial chemotherapy (Print). 1997, Vol 39, Num 3, pp 319-324, issn 0305-7453Article

Anaerobic susceptibility testing : slight differences in inoculum size can make a difference in minimum inhibitory concentrationsALDRIDGE, K. E; SCHIRO, D. D.Diagnostic microbiology and infectious disease. 1994, Vol 18, Num 3, pp 191-195, issn 0732-8893Article

In vitro activity of biapenem (L-627), a new carbapenem, against anaerobesALDRIDGE, K. E; MORICE, N; SCHIRO, D. D et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 4, pp 889-893, issn 0066-4804Article

Antimicrobial therapy of anaerobic infections, 1991SANDERS, C. V; ALDRIDGE, K. E.Pharmacotherapy. 1991, Vol 11, Num 2, pp 72S-79S, issn 0277-0008, p.2Article

Enhanced antimicrobial activity of old and new β-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by β-lactamase inhibitorsALDRIDGE, K. E; HENDERBERG, A; SANDERS, C. V et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 25, Num 5, pp 873-875, issn 0305-7453Article

Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-β-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locationsALDRIDGE, K. E; JANNEY, A; SANDERS, C. V et al.Antimicrobial agents and chemotherapy. 1985, Vol 28, Num 5, pp 634-638, issn 0066-4804Article